Current status and future trends in clinical research of bipolar disorder

Shanghai Archives of Psychiatry

Volumn 23, Issue 1, 2011, Pages 12-16

  Fang, Yi Ru ^a   Wang, Zuo Wei ^a,b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Mental Health Centre of Hongkou District   (China)

Author keywords

Bipolar Depression; Bipolar Disorder; Clinical Phenomenology; Comorbidity

Indexed keywords

EID: 84876333075     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1002-0829.2011.01.004     Document Type: Article

References (27)

1. 2009: 389-413.
2. Regier D A, Farmer M E, Rae D S, Locke B Z, Keith S J, Judd I X, et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA, 1990, 264(19): 2511-2518.
3. Judd L L, Akiskal H S. The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord, 2003, 73(1-2): 123-131.
4. Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W. Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord, 2003, 73(1-2): 133-146.
5. Merikangas K R, Akiskal H S, Angst J, Greenberg P E, Hirschfeld R M, Petukhova M, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry, 2007, 64(5): 543-552.
6. Lee S, Ng K L, Tsang A. A community survey of the twelve-month prevalence and correlates of bipolar spectrum disorder in Hong Kong. J Affect Disord, 2009, 117(1-2): 79-86.
7. Phillips M R, Zhang J, Shi Q, Song Z, Ding Z, Pang S, et al. Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey. Lancet, 2009, 373(9680): 2041-2053.
8. 1998, 31(2): 69-71.
9. Akiskal H S, Rosenthal R H, Rosenthal T L, Kashgarian M, Khani M K, Puzantian V R. Differentiation of primary affective illness from situational, symptomatic, and secondary depressions. Arch Gen Psychiatry, 1979, 36(6): 635-643.
10. Ghaemi S N, Ko J Y, Goodwin F K. " Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry, 2002, 47(2): 125-134.
11. 2005, 15(4): 249-250.
12. Ghaemi S N, Ko J Y, Goodwin F K. The bipolar spectrum and the antidepressant view of the world. J Psychiatr Pract, 2001, 7(5): 287-297.
13. Suppes T, Mintz J, McElroy S L, Altshuler L L, Kupka R W, Frye M A, et al. Mixed hypomania in 908 patients with bipolar disorder evaluated prospectively in the Stanley Foundation Bipolar Treatment Network. Arch Gen Psychiatry, 2005, 62(10): 1089-1096.
14. Hantouche E G, Angst J, Akiskal H S. Factor structure of hypomania: interrelationships with cyclothymia and the soft bipolar spectrum. J Affect Disord, 2003, 73(1-2): 39-47.
15. 2008, 34(11): 697-699.
16. Simon N M, Otto M W, Wisniewski S R, Fossey M, Sagduyu K, Frank E, et al. Anxiety disorder comorbidity in bipolar disorder patients: data from the first 500 participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry, 2004, 161(12): 2222-2229.
17. Tohen M, Vieta E, Galabrese J R, Ketter T A, Sachs G, Bowden G, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar disorder. Arch Gen Psychiatry, 2003, 60(11): 1079-1088.
18. Galabrese J R, Keck P E, Macfadden W, Minkwitz M, Ketter T A, Weisler R H, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry, 2005, 162(7): 1351-1360.
19. Oquendo M A, Currier D, Liu S M, Hasin D S, Grant B F, Blanco G, et al. Increased risk for suicidal behavior in comorbid bipolar disorder and alcohol use disorders: results from the National Epidemiologic Survey on Alcohol and Related Gonditions (NESARG). J Glin Psychiatry, 2010, 71(7): 902-909.
20. Kemp D E, Gao K, Ganocy S J, Elhaj O, Bilali S R, Gonroy G, et al. A 6-month, double-blind, maintenance trial of lithium monotherapy versus the combination of lithium and divalproex for rapid-cycling bipolar disorder and co-occurring substance abuse or dependence. J Glin Psychiatry, 2009, 70(1): 113-121.
21. Ostacher M J, Perlis R H, Nierenberg A A, Galabrese J, Stange J P, Salloum I, et al. Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry, 2010, 167(3): 289-297.
22. Garcia-Portilla M P, Saiz P A, Benabarre A, Sierra P, Perez J, Rodriguez A, et al. The prevalence of metabolic syndrome in patients with bipolar disorder. J Affect Disord, 2008, 106(1-2): 197-201.
23. Yumru M, Savas H A, Kurt E, Kaya M G, Selek S, Savas E, et al. A typical antipsychotics related metabolic syndrome in bipolar patients. J Affect Disord, 2007, 98(3): 247-252.
24. Osby U, Brandt L, Gorreia N, Ekbom A, Sparen P. Excess mortality in bipolar and unipolar disorder in Sweden. Arch Gen Psychiatry, 2001, 58(9): 844-850.
25. Fagiolini A, Frank E, Scott J A, Turkin S, Kupfer D J. Metabolic syndrome in bipolar disorder: findings from the bipolar disorder center for Pennsylvanians. Bipolar Disord, 2005, 7(5): 424-430.
26. Koponen H, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H. Metabolic syndrome predispose to depressive symptoms: a population-based 7-year follow-up study. J Glin Psychiatry, 2008, 69(2): 178-182.
27. Yatham L N, Kennedy S H, Schaffer A, Parikh S V, Beaulieu S, O'Donovan G, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord, 2009, 11(3): 225-255.